Gene · 93
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Muscle-bone crosstalk via endocrine signals and potential targets for osteosarcopenia-related fracture. | J Orthop Translat | 2023 | 38021216 | PubTator, text mining | PubMed |
| GDF8 inhibition enhances musculoskeletal recovery and mitigates posttraumatic osteoarthritis following joint injury. | Sci Adv | 2023 | 38019905 | PubTator, text mining | PubMed |
| Establishment and verification of a prognostic risk score model based on immune genes for hepatocellular carcinoma in an Asian population. | Transl Cancer Res | 2023 | 37969383 | PubTator, text mining | PubMed |
| Deep learning of human polyadenylation sites at nucleotide resolution reveals molecular determinants of site usage and relevance in disease. | Nat Commun | 2023 | 37968271 | PubTator, text mining | PubMed |
| Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trial. | PLoS One | 2023 | 37963137 | PubTator, text mining | PubMed |
| Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma. | Nat Genet | 2023 | 37945900 | PubTator, text mining | PubMed |
| D3-creatine dilution, computed tomography and dual-energy X-ray absorptiometry for assessing myopenia and physical function in colon cancer: A cross-sectional study. | J Cachexia Sarcopenia Muscle | 2023 | 37899757 | PubTator, text mining | PubMed |
| MicroRNA Expression Patterns Reveal a Role of the TGF-β Family Signaling in AML Chemo-Resistance. | Cancers (Basel) | 2023 | 37894453 | PubTator, text mining | PubMed |
| Adipocyte dysfunction promotes lung inflammation and aberrant repair: a potential target of COPD. | Front Endocrinol (Lausanne) | 2023 | 37886639 | PubTator, text mining | PubMed |
| An interactive resource of molecular signalling in the developing human haematopoietic stem cell niche. | Development | 2023 | 37840454 | PubTator, text mining | PubMed |
| Methylomics and cancer: the current state of methylation profiling and marker development for clinical care. | Cancer Cell Int | 2023 | 37840147 | PubTator, text mining | PubMed |
| Current Nutritional and Pharmacological Approaches for Attenuating Sarcopenia. | Cells | 2023 | 37830636 | PubTator, text mining | PubMed |
| Transcriptome analysis of osteogenic differentiation of human maxillary sinus mesenchymal stem cells using RNA-Seq. | Heliyon | 2023 | 37800070 | PubTator, text mining | PubMed |
| Predictors of biliary atresia outcome: Saudi National Study (2000 - 2018). | Saudi J Gastroenterol | 2023 | 37787348 | PubTator, text mining | PubMed |
| Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial. | Nat Med | 2023 | 37770652 | PubTator, text mining | PubMed |
| Emerging Gene Therapy Approaches in the Management of Spinal Muscular Atrophy (SMA): An Overview of Clinical Trials and Patent Landscape. | Int J Mol Sci | 2023 | 37762045 | PubTator, text mining | PubMed |
| Stress Urinary Incontinence: An Unsolved Clinical Challenge. | Biomedicines | 2023 | 37760927 | PubTator, text mining | PubMed |
| Myoglobin in Brown Adipose Tissue: A Multifaceted Player in Thermogenesis. | Cells | 2023 | 37759463 | PubTator, text mining | PubMed |
| Cancer Cachexia: Underlying Mechanisms and Potential Therapeutic Interventions. | Metabolites | 2023 | 37755304 | PubTator, text mining | PubMed |
| Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity. | Cell Rep Med | 2023 | 37734378 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/93/papers?page=5